HCA Healthcare, Inc. (NYSE:HCA) is Sivik Global Healthcare LLC’s 8th Largest Position

Sivik Global Healthcare LLC increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 42.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,000 shares of the company’s stock after buying an additional 7,500 shares during the quarter. HCA Healthcare accounts for about 2.9% of Sivik Global Healthcare LLC’s portfolio, making the stock its 8th largest position. Sivik Global Healthcare LLC’s holdings in HCA Healthcare were worth $8,032,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. International Assets Investment Management LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter worth $4,030,000. Atria Wealth Solutions Inc. raised its holdings in HCA Healthcare by 50.7% in the 4th quarter. Atria Wealth Solutions Inc. now owns 2,529 shares of the company’s stock valued at $685,000 after acquiring an additional 851 shares during the last quarter. Transcend Capital Advisors LLC increased its stake in HCA Healthcare by 4.8% during the fourth quarter. Transcend Capital Advisors LLC now owns 1,187 shares of the company’s stock worth $321,000 after acquiring an additional 54 shares during the last quarter. Mather Group LLC. acquired a new stake in HCA Healthcare in the fourth quarter valued at approximately $224,000. Finally, Auxano Advisors LLC acquired a new stake in HCA Healthcare during the fourth quarter valued at approximately $372,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Up 0.7 %

Shares of HCA stock traded up $2.80 during trading on Friday, hitting $395.59. 884,271 shares of the stock traded hands, compared to its average volume of 1,126,563. The firm has a market capitalization of $103.61 billion, a P/E ratio of 19.72, a price-to-earnings-growth ratio of 1.39 and a beta of 1.68. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The firm’s fifty day moving average price is $348.60 and its 200-day moving average price is $332.96. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $395.91.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating the consensus estimate of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. During the same period in the prior year, the company earned $4.29 earnings per share. The company’s revenue was up 10.3% compared to the same quarter last year. As a group, research analysts forecast that HCA Healthcare, Inc. will post 22.43 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a $0.66 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a yield of 0.67%. HCA Healthcare’s payout ratio is currently 13.16%.

Analyst Upgrades and Downgrades

HCA has been the topic of several recent analyst reports. Wells Fargo & Company boosted their target price on HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 30th. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. UBS Group upped their price objective on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research note on Monday, August 19th. Finally, Robert W. Baird assumed coverage on shares of HCA Healthcare in a report on Thursday, May 30th. They issued an “outperform” rating and a $396.00 target price on the stock. Four analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $356.17.

Insiders Place Their Bets

In related news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares of the company’s stock, valued at approximately $14,569,729.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, SVP Kathleen M. Whalen sold 2,987 shares of the company’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the transaction, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80. The disclosure for this sale can be found here. Over the last three months, insiders have sold 8,844 shares of company stock valued at $3,185,932. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.